Hours of testimony in a Pa. courtroom on Ozempic and other GLP-1s could reshape lawsuit against drugmakers
MENU ACCOUNT SECTIONS OTHER CLASSIFIEDS CONTACT US / FAQ No Byline Policy Editorial Guidelines Corrections Policy Source
Read MoreMENU ACCOUNT SECTIONS OTHER CLASSIFIEDS CONTACT US / FAQ No Byline Policy Editorial Guidelines Corrections Policy Source
Read MoreThe Doctor (Ncuti Gatwa) seems to be heading for a family reunion of some kind on Doctor Who — and
Read MorePharmaceutical Executive recently conducted an in-depth survey on the current landscape and potential outlook for the life sciences industry, drawing
Read MoreHi, Carolyn: After spending my entire adult life fighting my weight and being medically classified as overweight, then obese, I
Read Morenew video loaded: Doctors Heal Infant Using First Customized-Gene Editing Treatment transcript Back transcript Doctors Heal Infant Using First Customized-Gene
Read MoreHelp wanted: Healthcare professionals who “do exceptional things” and “refuse to accept medicine as it is.” Those who are “unsatisfied,
Read MoreAfter telehealth startups recently lost the ability to sell exact copies of patented GLP-1 weight-loss drugs, some firms have begun
Read MoreIt feels like tofu. If you’re wondering what feels like tofu, it’s the human brain that fifth graders got to
Read MoreSanofi’s illuminated logo displayed at the fifth China International Import Expo (CIIE) in Shanghai, China, on November 6, 2022. (Adobe
Read MoreWhile it still isn’t clear how US President Donald Trump’s new executive order on reducing prices of prescription drugs by
Read More